# A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

> **NCT00389896** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 150 (—)

## Conditions studied

- HDL Cholesterol

## Interventions

- **DRUG:** MK0733 / Duration of Treatment: 18 Weeks
- **DRUG:** Comparator: placebo (unspecified) / Duration of Treatment: 18 Weeks

## Key facts

- **NCT ID:** NCT00389896
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07-26
- **Primary completion:** 2002-10-04
- **Final completion:** 2002-10-04
- **Target enrollment:** 150 (—)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389896, "A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00389896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*